Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov 6:17:263-271.
doi: 10.1016/j.nicl.2017.10.022. eCollection 2018.

Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome

Natalie Neale  1 , Concepcion Padilla  2 , Luciana Mascarenhas Fonseca  3 , Tony Holland  2 , Shahid Zaman  2
Affiliations
Review

Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome

Natalie Neale et al. Neuroimage Clin. .

Abstract

People with Down syndrome (DS) develop Alzheimer's disease (AD) at higher rates and a younger age of onset compared to the general population. As the average lifespan of people with DS is increasing, AD is becoming an important health concern in this group. Neuroimaging is becoming an increasingly useful tool in understanding the pathogenesis of dementia development in relation to clinical symptoms. Furthermore, neuroimaging has the potential to play a role in AD diagnosis and monitoring of therapeutics. This review describes major recent findings from in vivo neuroimaging studies analysing DS and AD via ligand-based positron emission tomography (PET), [18F] fluorodeoxyglucose (FDG)-PET, structural magnetic resonance imaging (sMRI), and diffusion tensor imaging (DTI). Electroencephalography (EEG) and retinal imaging are also discussed as emerging modalities. The review is organized by neuroimaging method and assesses the relationship between cognitive decline and neuroimaging changes. We find that amyloid accumulation seen on PET occurs prior to dementia onset, possibly as a precursor to the atrophy and white matter changes seen in MRI studies. Future PET studies relating tau distribution to clinical symptoms will provide further insight into the role this protein plays in dementia development. Brain activity changes demonstrated by EEG and metabolic changes seen via FDG-PET may also follow predictable patterns that can help track dementia progression. Finally, newer approaches such as retinal imaging will hopefully overcome some of the limitations of neuroimaging and allow for detection of dementia at an earlier stage.

Keywords: AD, Alzheimer's disease; APP, amyloid precursor protein; Aβ, amyloid beta; Biomarkers; DS, Down syndrome; DTI, diffusion tensor imaging; Dementia; Diffusion tensor imaging (DTI); EEG, electroencephalography; Electroencephalography (EEG); FDG, fluordexoyglucose; Magnetic resonance imaging (MRI); NFT, neurofibrillary tangles; PET, positron emission tomography; Positron emission tomography (PET); sMRI, structural magnetic resonance imaging.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Annus T., Wilson L.R., Hong Y.T., Acosta-Cabronero J., Fryer T.D., Cardenas-Blanco A.…Holland A.J. The pattern of amyloid accumulation in the brains of adults with Down syndrome. Alzheimers Dement. 2016;12(5):538–545. - PMC - PubMed
    1. Annus T., Wilson L.R., Acosta-Cabronero J., Cardenas-Blanco A., Hong Y.T., Fryer T.D.…Nestor P.J. The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis. Neurobiol. Aging. 2017;53:11–19. - PMC - PubMed
    1. Antonarakis S.E., Lyle R., Dermitzakis E.T., Reymond A., Deutsch S. Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nat. Rev. Genet. 2004;5(10):725–738. - PubMed
    1. Babiloni C., Albertini G., Onorati P., Muratori C., Buffo P., Condoluci C.…Rossini P.M. Cortical sources of EEG rhythms are abnormal in Down syndrome. Clin. Neurophysiol. 2010;121(8):1205–1212. - PubMed
    1. Beacher F., Daly E., Simmons A., Prasher V., Morris R., Robinson C.…Murphy D.G.M. Alzheimer's disease and Down's syndrome: an in vivo MRI study. Psychol. Med. 2009;39(4):675–684. - PubMed